MedTrace Logo

Salivary and Serum Levels of Chemerin and MMP-9 in Oral Premalignant and Malignant Lesions

NCT02323672 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2017-02-10

No results posted yet for this study

Summary

45 individuals were subdivided into 3 groups, 15 patients with oral premalignant lesions, 15 patients with oral malignant lesions and 15 control individuals. Levels of chemerin and MMP-9 were evaluated in serum and saliva of these subjects utilizing the ELISA technique.

Conditions

  • Precancerous Conditions
  • Oral Cancer

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Noha Ghallab, M.D. · Associate Professor of periodontology and Oral Medicine faulty of oral and dental medicine Cairo Unv.

Eligibility

Min Age
40 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2014-09-30
Completion
2014-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02323672 on ClinicalTrials.gov